Page 9 of 19 – SEC Filing CUSIP No. 09058V103 Page 9 of 15
1. Name of Reporting Persons Koh, Bong 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) x1 (b) ¨ 3. SEC USE ONLY 4. Citizenship or Place of Organization United States Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 6. Shared Voting Power 5,241,3782 7. Sole Dispositive Power 0 8. Shared Dispositive Power 5,241,3782 9. Aggregate Amount Beneficially Owned by Each Reporting Person 5,241,3782 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨ 11. Percent of Class Represented by Amount in Row (9) 7.1%3 12. Type of Reporting Person (See Instructions) IN
1 Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G.
2 Consists of 473,101 shares owned by Venrock Healthcare Capital Partners, L.P., 86,542 shares owned by VHCP Co-Investment Holdings, LLC, 3,331,104 shares owned by Venrock Healthcare Capital Partners II, L.P. and 1,350,631 shares owned by VHCP Co-Investment Holdings II, LLC.
3 This percentage is calculated based upon 73,629,816 shares of the Issuer’s common stock outstanding as of January 31, 2016, as set forth in the Issuer’s annual report on Form 10-K filed with the Securities and Exchange Commission on February 26, 2016.
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP No. 09058V103 | Page 9 of 15 |
| 1. | Name of Reporting Persons Koh, Bong | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions) (a) x1 (b) ¨ | |||||
| 3. | SEC USE ONLY | |||||
| 4. | Citizenship or Place of Organization United States | |||||
| Number of Shares Beneficially Owned by Each Reporting Person With: | | 5. | | Sole Voting Power 0 | ||
| | 6. | | Shared Voting Power 5,241,3782 | |||
| | 7. | | Sole Dispositive Power 0 | |||
| | 8. | | Shared Dispositive Power 5,241,3782 | |||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person 5,241,3782 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨ | |||||
| 11. | Percent of Class Represented by Amount in Row (9) 7.1%3 | |||||
| 12. | Type of Reporting Person (See Instructions) IN | |||||
| 1 | Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G. |
| 2 | Consists of 473,101 shares owned by Venrock Healthcare Capital Partners, L.P., 86,542 shares owned by VHCP Co-Investment Holdings, LLC, 3,331,104 shares owned by Venrock Healthcare Capital Partners II, L.P. and 1,350,631 shares owned by VHCP Co-Investment Holdings II, LLC. |
| 3 | This percentage is calculated based upon 73,629,816 shares of the Issuer’s common stock outstanding as of January 31, 2016, as set forth in the Issuer’s annual report on Form 10-K filed with the Securities and Exchange Commission on February 26, 2016. |
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
